Genome Research Technology Offers

Yissum - Research Development Company of the Hebrew University posted this:

Platform for Neutrophil Specific Targeting as a Mode of Immunotherapy Dr. Zvika Granot, from the School of Medicine-IMRIC-Developmental Biology and Cancer Research, is working on a innovative approach for Neutrophil specific targeting of TGF-beta signaling as a novel anti-cancer therapy (see attached summary and several papers) Project ID : 6-2015-4241

Platform for Neutrophil Specific Targeting as a Mode of Immunotherapy

Yissum - Research Development Company of the Hebrew University posted this:

Personalized Phage Therapy: A New Paradigm for Combating Infectious Disease in the Age of Antibiotic Resistance A New Paradigm for Combating Infectious Disease in the Age of Antibiotic Resistance. Phage Therapy offers significant advantages: 1) Natural- Harnessing nature’s own enemy against bacteria 2) Smart kinetics Phages grow with bacteria and disappear in its absence 3) Can be manipulated (unlike antibiotics) Engineered / evolutionary developed 4) Efficient against biofilm Chain reaction of the phages 5) Do not harm the microbiome Highly specific to the target pathogen. Hazan's approach for a Personalized Phage Therapy suggests an adaptive and dynamic cocktail of phages and antibiotics , that are specially tailored using AI and machine learning prediction. Hazan et.al. offer a constantly increasing “Bank” of phages. Project ID : 43-2019-10746

Personalized Phage Therapy: A New Paradigm for Combating Infectious Disease in the Age of Antibiotic Resistance

Yissum - Research Development Company of the Hebrew University posted this:

Novel Drug Delivery System of Large Molecules for Localized Sustained Release Novel Drug Delivery System of Large Molecules for Localized Sustained Release Project ID : 6-2018-4643

Yissum - Research Development Company of the Hebrew University posted this:

Novel Chimeric System for Targeted Killing of Lymphocytic Cancer Cells Novel Chimeric Protein utilizing components of the Ubiquitin-Proteasome System for targeted killing of Lymphocytic Cancer Cells Project ID : 6-2018-4687

Yissum - Research Development Company of the Hebrew University posted this:

New Methodology to Control Calcium Carbonate Morphology and Material State New Methodology to Control Calcium Carbonate Morphology and Material State Project ID : 6-2018-4599

Yissum - Research Development Company of the Hebrew University posted this:

New Target for the Treatment of Abdominal Obesity New target for the treatment of obesity and abdominal obesity by inhibiting the FGFR3 receptor signalling pathway Project ID : 7-2018-4658

Yissum - Research Development Company of the Hebrew University posted this:

Novel Method for Identifying Personalized Anti-Cancer Drug Combinations NanoCode - Identifying Best Fit Cancer Drug Combinations In-Vivo Project ID : 6-2019-6704

Yissum - Research Development Company of the Hebrew University posted this:

miRNA-Responsive Drug-Loaded NMOFs for the Targeted Treatment of Cancer miRNA-Responsive Drug-Loaded NMOFs for the Targeted Treatment of Cancer Project ID : 6-2019-6706

miRNA-Responsive Drug-Loaded NMOFs for the Targeted Treatment of Cancer

Yissum - Research Development Company of the Hebrew University posted this:

Computational Tool for the Design of Personalized Drug Cocktails, Based on Intra-Tumor Subpopulations A computational approach to map intra-tumor subpopulations for the rational design of individualized cancer drug cocktails Project ID : 6-2019-7741

Yissum - Research Development Company of the Hebrew University posted this:

A Non-Narcotic Synergic Drug Combination for the Treatment of Severe Chronic Pain Novel synergic drug-combination for improved activation of the human opioid receptor (MOR), with expected avoidance of drug-addiction, using lower effective clinical doses Avoiding Drug Addiction Using a Novel Drug Combination for Improved Activation of the Opioid Receptor Project ID : 6-2018-5679

Yissum - Research Development Company of the Hebrew University posted this:

Synthetic Gene Circuits With Improved Safety Synthetic Gene Circuits With Improved Safety Project ID : 6-2019-8748

Yissum - Research Development Company of the Hebrew University posted this:

Cannabinoid-based Drugs for Preventing Age-Related Osteoarthritis Cannabinoid-based Drugs for Preventing Age-Related Osteoarthritis Project ID : 46-2019-10768

Yissum - Research Development Company of the Hebrew University posted this:

Identifying and Optimizing Treatment for Neuropathic Pain Identifying and Optimizing Treatment for Neuropathic Pain Project ID : 6-2019-9749

Identifying and Optimizing Treatment for Neuropathic Pain

Ukrainian Laboratories posted this:

Computer aided drug discovery services Otava Research Institute helps researchers around the world develop advanced solutions for the variety of research projects maximizing their efficiencies, and, most of all, respecting their budgets. Our experts are involved in the development of leading compounds at any stage of the R&D process: starting from target identification to lead optimization

Computer aided drug discovery services

IDIBELL posted this:

Exosomal miRNAs in seminal plasma as non-invasive markers of prostate cancer diagnosis Identified miRNAs, from the semen samples, could be used as non-invasive biomarkers that contribute in the diagnosis/prognosis of malignant prostate cancer.

Exosomal miRNAs in seminal plasma as non-invasive markers of prostate cancer diagnosis

1
2
3
4
5